Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [Elsevier BV]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
小蘑菇应助追寻梦易采纳,获得10
1秒前
量子星尘发布了新的文献求助10
1秒前
2秒前
杨blinh完成签到,获得积分10
2秒前
酷酷李可爱婕完成签到 ,获得积分10
4秒前
4秒前
nashanbei发布了新的文献求助10
4秒前
Bryce完成签到 ,获得积分10
4秒前
4秒前
John_snape完成签到,获得积分10
5秒前
FashionBoy应助yefeng采纳,获得10
6秒前
6秒前
英姑应助66采纳,获得10
6秒前
hefang完成签到,获得积分10
6秒前
7秒前
Jasper应助时雨采纳,获得30
8秒前
FashionBoy应助Tang采纳,获得30
9秒前
天天快乐应助erhao采纳,获得10
9秒前
迅猛2002发布了新的文献求助10
9秒前
任性白容完成签到,获得积分10
9秒前
xz发布了新的文献求助10
10秒前
10秒前
赘婿应助王宏峰采纳,获得10
10秒前
hopen发布了新的文献求助10
11秒前
含糊的冰淇淋完成签到,获得积分10
11秒前
bkagyin应助pupu采纳,获得10
11秒前
11秒前
嗯呢嗯呢应助August采纳,获得200
12秒前
13秒前
脑洞疼应助磕学少女采纳,获得10
13秒前
14秒前
量子星尘发布了新的文献求助10
14秒前
乐乐应助小鱼儿采纳,获得10
16秒前
16秒前
星辰大海应助如沐风采纳,获得10
16秒前
feifei发布了新的文献求助10
16秒前
充电宝应助迅猛2002采纳,获得10
17秒前
SciGPT应助勤劳的音响采纳,获得10
18秒前
秀丽雁芙发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
《微型计算机》杂志2006年增刊 1600
Einführung in die Rechtsphilosophie und Rechtstheorie der Gegenwart 1500
Binary Alloy Phase Diagrams, 2nd Edition 1000
DESIGN GUIDE FOR SHIPBOARD AIRBORNE NOISE CONTROL 600
NMR in Plants and Soils: New Developments in Time-domain NMR and Imaging 600
Electrochemistry: Volume 17 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4959120
求助须知:如何正确求助?哪些是违规求助? 4219993
关于积分的说明 13139275
捐赠科研通 4003365
什么是DOI,文献DOI怎么找? 2190793
邀请新用户注册赠送积分活动 1205401
关于科研通互助平台的介绍 1116823